Galapagos reacquires GLPG0634 rights

Galapagos N.V. (Euronext:GLPG; Pink:GLPYY) reacquired all rights to GLPG0634 for an undisclosed amount from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), which had an option under an ongoing 2006 deal to l...